X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1952) 1952
Publication (137) 137
Newspaper Article (68) 68
Newsletter (59) 59
Book / eBook (50) 50
Book Review (32) 32
Book Chapter (23) 23
Magazine Article (6) 6
Conference Proceeding (3) 3
Dissertation (2) 2
Transcript (2) 2
Web Resource (2) 2
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1289) 1289
humans (1037) 1037
diabetes (998) 998
animals (939) 939
male (927) 927
oxidative stress (521) 521
cardiomyopathy (493) 493
endocrinology & metabolism (486) 486
rats (471) 471
female (460) 460
diabetes mellitus (458) 458
risk factors (377) 377
cardiac & cardiovascular systems (366) 366
diabetic cardiomyopathy (365) 365
middle aged (336) 336
heart (334) 334
research (325) 325
heart diseases (320) 320
type 2 diabetes (319) 319
diabetics (290) 290
glucose (283) 283
mice (271) 271
mortality (270) 270
apoptosis (269) 269
diabetes mellitus, type 2 - complications (268) 268
heart failure (268) 268
rodents (268) 268
cardiovascular disease (267) 267
aged (265) 265
care and treatment (263) 263
diabetes mellitus, type 2 - drug therapy (256) 256
diabetic cardiomyopathies - drug therapy (256) 256
health aspects (252) 252
diabetes mellitus, experimental - drug therapy (228) 228
pharmacology & pharmacy (226) 226
inflammation (222) 222
hyperglycemia (221) 221
diabetic cardiomyopathies - prevention & control (218) 218
hypoglycemic agents - therapeutic use (218) 218
proteins (214) 214
myocardium - metabolism (213) 213
mellitus (210) 210
hypertension (209) 209
fibrosis (208) 208
diabetic cardiomyopathies - metabolism (203) 203
medicine (203) 203
heart-failure (198) 198
oxidative stress - drug effects (196) 196
insulin (193) 193
medicine, research & experimental (192) 192
streptozocin (192) 192
cardiovascular diseases (189) 189
metabolism (189) 189
analysis (188) 188
myocardium - pathology (181) 181
research article (179) 179
rats, sprague-dawley (177) 177
diabetic cardiomyopathies - physiopathology (176) 176
review (174) 174
diabetes mellitus, experimental - complications (169) 169
physiology (165) 165
physiological aspects (164) 164
insulin-resistance (163) 163
complications (161) 161
diabetic retinopathy (159) 159
rats, wistar (159) 159
adult (158) 158
blood glucose - metabolism (158) 158
diabetic cardiomyopathies - pathology (158) 158
studies (157) 157
insulin resistance (156) 156
complications and side effects (155) 155
disease models, animal (153) 153
diabetes mellitus, experimental - metabolism (146) 146
disease (146) 146
kinases (146) 146
medical research (144) 144
expression (142) 142
cell biology (140) 140
dysfunction (138) 138
diabetes therapy (137) 137
treatment outcome (137) 137
cardiology (133) 133
gene expression (131) 131
heart attacks (131) 131
antioxidants (130) 130
apoptosis - drug effects (129) 129
activation (127) 127
echocardiography (125) 125
drug therapy (124) 124
myocardial-infarction (124) 124
risk (123) 123
diabetic cardiomyopathies - etiology (118) 118
prevention (118) 118
signal transduction (116) 116
article subject (114) 114
signal transduction - drug effects (114) 114
blood pressure (113) 113
diabetes mellitus, type 2 - blood (111) 111
multidisciplinary sciences (111) 111
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (40) 40
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Online Resources - Online (3) 3
Credit Valley Hospital - Stacks (2) 2
Providence Healthcare - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2123) 2123
Chinese (12) 12
Spanish (7) 7
German (6) 6
French (5) 5
Italian (5) 5
Portuguese (4) 4
Russian (3) 3
Polish (2) 2
Ukrainian (2) 2
Arabic (1) 1
Romanian (1) 1
Romansh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e52013
Objectives: Diabetic cardiomyopathy (DCM), characterized by myocardial structural and functional changes, is an independent cardiomyopathy that develops in... 
FIBROSIS | CELLS | OXIDATIVE STRESS | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | GENE-EXPRESSION | CARDIAC DYSFUNCTION | PPAR-GAMMA | RECEPTOR | GLYCATION END-PRODUCTS | DIASTOLIC DYSFUNCTION | Inflammation - pathology | Diabetes Mellitus, Experimental - drug therapy | Fibrosis - drug therapy | Diabetic Cardiomyopathies - metabolism | Diabetic Cardiomyopathies - drug therapy | Rats, Wistar | Apoptosis - drug effects | Diabetes Mellitus, Experimental - genetics | Apoptosis - genetics | Glycogen Synthase Kinase 3 beta | Male | Fibrosis - metabolism | Proto-Oncogene Proteins c-akt - genetics | Inflammation - metabolism | Cell Death - genetics | Ventricular Dysfunction, Left - genetics | Inflammation - drug therapy | Myocardium - metabolism | Ventricular Dysfunction, Left - pathology | Cell Death - drug effects | Phosphorylation - drug effects | Diabetes Mellitus, Experimental - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Receptor for Advanced Glycation End Products | Fibrosis - genetics | Curcumin - pharmacology | Oxidative Stress - genetics | Rats | Myocardium - pathology | Glycogen Synthase Kinase 3 - metabolism | Diabetic Cardiomyopathies - genetics | Ventricular Dysfunction, Left - metabolism | Animals | Ventricular Dysfunction, Left - drug therapy | Glycogen Synthase Kinase 3 - genetics | Diabetes Mellitus, Experimental - pathology | Heart - drug effects | Inflammation - genetics | Diabetic Cardiomyopathies - pathology | Fibrosis - pathology | Oxidative Stress - drug effects | Receptors, Immunologic - genetics | Receptors, Immunologic - metabolism | Oxidases | Heart | Biological products | Cardiomyopathy | Heart diseases | Enzyme-linked immunosorbent assay | Apoptosis | Oxidative stress | Phosphorylation | Bax protein | Bcl-2 protein | Science | AKT protein | Cardiovascular disease | Caspase-3 | NAD(P)H oxidase | Accumulation | Proteins | Signal transduction | Hyperglycemia | Ultrastructure | Biochemical tests | Curcumin | Age | Energy intake | Enzymes | Advanced glycosylation end products | Echocardiography | Abnormalities | Diabetes mellitus | Caspase | Rac1 protein | Pharmacology | Inflammation | Glycosylation | IL-1β | Gene expression | Metabolism | Studies | Signaling | Cell death | Fibrosis | Diabetes | Aberration | Laboratory animals | Metabolic disorders | Hypertrophy
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 56, Issue 25, pp. 2115 - 2125
Objectives In this study, we have investigated the effects of cannabidiol (CBD) on myocardial dysfunction, inflammation, oxidative/nitrative stress, cell... 
Cardiovascular | Internal Medicine | diabetic complications | cannabinoids | inflammation | oxidative stress | CONSTITUENT | CARDIAC & CARDIOVASCULAR SYSTEMS | METALLOTHIONEIN | MITOCHONDRIAL | ENDOCANNABINOID SYSTEM | ANTAGONISM | PROTECTS | INHIBITION | DISEASE | NF-KAPPA-B | Diabetic Cardiomyopathies - metabolism | Reactive Oxygen Species - metabolism | Diabetic Cardiomyopathies - drug therapy | Apoptosis - drug effects | Humans | Body Weight - drug effects | Male | NF-kappa B - metabolism | Glucose | Cannabidiol - therapeutic use | Drug Evaluation, Preclinical | Disease Models, Animal | Mice, Inbred C57BL | Cells, Cultured | Pancreas - drug effects | Cannabidiol - pharmacology | Myocardium - pathology | Pancreas - metabolism | Blood Glucose - drug effects | Insulin - metabolism | Animals | MAP Kinase Signaling System - drug effects | Myocytes, Cardiac - drug effects | Fibrosis | Diabetic Cardiomyopathies - pathology | Hemodynamics - drug effects | Mice | Oxidative Stress - drug effects | Phosphates | Oxidative stress | Medical colleges | Niacinamide | Cardiomyopathy | Alcoholism | Radiation | Superoxide | Biochemistry | Dextrose | Purines | Cannabinoids | Cell death | Analysis | Nitric oxide | Protein kinases | Heart diseases | Adenosine triphosphatase | Jewish schools | Mortality | Cardiovascular disease | Cardiomyocytes | Kinases | Experiments | Variance analysis | Antioxidants | Proteins | Polymerase chain reaction | Rodents | Atherosclerosis | Diabetes | Pancreas | Apoptosis
Journal Article
Circulation, ISSN 0009-7322, 05/2012, Volume 125, Issue 19, pp. 2323 - 2333
Background-cGMP phosphodiesterase type 5 protein is upregulated in myocardial hypertrophy. However, it has never been ascertained whether phosphodiesterase... 
fibrosis | phosphodiesterase inhibitors heart failure | diabetes mellitus type 2 | cardiac magnetic resonance imaging | diabetic diastolic heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | PULMONARY-HYPERTENSION | ENDOTHELIAL DYSFUNCTION | SILDENAFIL CITRATE | AORTIC-STENOSIS | DIASTOLIC HEART-FAILURE | HYPERTROPHY | FLOW-MEDIATED DILATATION | NITRIC-OXIDE | VALVE-REPLACEMENT | PERIPHERAL VASCULAR DISEASE | TYPE-5 INHIBITION | Piperazines - administration & dosage | Diabetic Cardiomyopathies - drug therapy | Follow-Up Studies | Phosphodiesterase 5 Inhibitors - adverse effects | Humans | Middle Aged | Sulfones - adverse effects | Magnetic Resonance Imaging - methods | Male | Purines - administration & dosage | Torsion, Mechanical | Sildenafil Citrate | Hypertrophy, Left Ventricular - pathology | Purines - adverse effects | Cardiac Imaging Techniques - methods | Hypertrophy, Left Ventricular - drug therapy | Cyclic Nucleotide Phosphodiesterases, Type 5 - metabolism | Diabetes Mellitus, Type 2 - complications | Phosphodiesterase 5 Inhibitors - administration & dosage | Treatment Outcome | Piperazines - adverse effects | Diabetic Cardiomyopathies - pathology | Aged | Ventricular Remodeling - drug effects | Sulfones - administration & dosage | Care and treatment | Magnetic resonance imaging | Cardiomyopathy | Clinical trials | Diagnosis | Phosphodiesterases | Heart diseases | Health aspects | Methods
Journal Article